TI
LFSC

Tidal Investments’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Tidal Investments’s Portfolio LFSC Stock Details LFSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790K Sell
17,474
-2,484
-12% -$96.1K ﹤0.01% 1860
2026
Q1 		$698K Buy
19,958
+2,954
+17% +$105K ﹤0.01% 1677
2025
Q4 		$623K Buy
+17,004
New +$583K ﹤0.01% 1525

Other funds holding LFSC

EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
CCWP
Cedar Cove Wealth Partners Bloomington, Minnesota $213M AUM
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
OPA
Old Port Advisors Portland, Maine $508M AUM 50.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Tidal Investments's LFSC Position: Q2 2026 in Review

Tidal Investments reduced its F/m Emerald Life Sciences Innovation ETF (LFSC) stake by 12% in Q2 2026, selling an estimated $96.1K and leaving 17,474 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

Tidal Investments first reported a position in LFSC in Q4 2025 and has held it in 3 quarters since. 8 funds tracked by Wall St. Rank hold LFSC as of Q2 2026.

  • Tidal Investments held 17,474 shares of F/m Emerald Life Sciences Innovation ETF worth $790K as of Q2 2026.
  • Tidal Investments sold 2,484 F/m Emerald Life Sciences Innovation ETF shares in Q2 2026, an estimated $96.1K.
  • F/m Emerald Life Sciences Innovation ETF made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1860 holding.
  • Tidal Investments first reported a position in F/m Emerald Life Sciences Innovation ETF in Q4 2025 and has held it in 3 quarters since.
  • 8 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.